The Effect of Nurse Training on the Improvement of Subcutaneous Heparin Applications

July 19, 2022 updated by: Demet İnangil, PhD, Istanbul Saglik Bilimleri University

Hamidiye Faculty of Nursing, University of Health Sciences

One of the most important duties and responsibilities of nurses is drug administration. During drug administration, the nurse uses appropriate administration techniques and ensures patient safety by knowing the drugs and their side effects. This study aimed to examine the effect of nurse training on the improvement of subcutaneous heparin applications. In this study, it was planned to train nurses by using two different training methods. These methods are online and face-to-face training.

In both methods, it was planned to evaluate the subcutaneous drug administration knowledge and skill of nurses before and after the training.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Drug administration is a common nursing clinical intervention. The nurse ensures patient safety by using compatible administration techniques and being aware of the side effects of medications. Pharmacological agents such as heparins, vaccines, insulin, hormone drugs, etc., are generally inappropriate with oral, intravenous or intamuscular intake. Thereupon, they have to be administered by means of subcutaneous (SC) injection. Subcutaneous medications are injected into the tissue layer between the skin and the muscle that is called subcutaneous tissue where does not have a rich blood supply. Suitable areas for subcutaneous injction application are the lateral aspect of the upper arms, posterior aspect of the upper arms, anterior surface of the thigh, unders the scapulas and abdomen in the umbilical region. For the reason that abdominal region has an excess subcutaneous fat tissue, enough space for repeated injections and less muscle activity, it is highly preferred for subcutaneous injections. The angle of entry of the needle into the tissue depends on the needle length and the thickness of the subcutaneous tissue mass. A 90-degree angle is used if the subcutaneous tissue thicknes is about 5 cm. However, when it is 2.5 cm the angle of a 45-degree angle is recommended. To check whether the needle tip is in the vein or not during the application causes the needle movement in the tissue that then results in vascular damage, bleeding, ecchymosis and hematoma formation. Airlock technique in subcutaneous inections is recommended as it ensures that the entire drug is delivered to the tissue as well as preventing the escape of the drug.

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • volunteering to participate in the study

Exclusion Criteria:

  • not have administered subcutaneous heparin in the clinical practice

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
Nurses in the experimental group participated in mobile-based video learning.
Nurses in the experimental group participated in mobile-based video learning.
Other Names:
  • SC Heparin Interventions
Active Comparator: Control
Nurses in the experimental group participated in face-to-face learning.
Nurses in the experimental group participated in face-to-face learning.
Other Names:
  • SC Heparin Interventions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improvement of subcutaneous heparin applications
Time Frame: Through study completion, an average of 1 months
The primary outcome of this study is the improvement of nurses' subcutaneous heparin applications. The 25-item checklist prepared by the researchers based on the literature includes the application steps of subcutaneous heparin knowledge and skill.
Through study completion, an average of 1 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparision of two different method
Time Frame: Through study completion, an average of 1 months
The secondary outcome of this study is the comparison of the two different education methods.The 25-item checklist prepared by the researchers based on the literature includes the application steps of subcutaneous heparin knowledge and skill.
Through study completion, an average of 1 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Demet İnangil, Istanbul Saglık Bilimleri University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

July 15, 2022

Primary Completion (Anticipated)

August 10, 2022

Study Completion (Anticipated)

August 30, 2022

Study Registration Dates

First Submitted

June 30, 2022

First Submitted That Met QC Criteria

July 19, 2022

First Posted (Actual)

July 21, 2022

Study Record Updates

Last Update Posted (Actual)

July 21, 2022

Last Update Submitted That Met QC Criteria

July 19, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nursing Care

Clinical Trials on Mobile-based video

3
Subscribe